Purthanol Resources Limited (PURT) 10-K/A 19 Mar 14 2013 FY Annual report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Nov. 30, 2013	Mar. 13, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Purthanol Resources Ltd	'
Entity Central Index Key	'0001126162	'
Document Type	'10-K	'
Document Period End Date	30-Nov-13	'
Amendment Flag	'true	'
Amendment description	'This amendment is for the sole purpose of filing the XBRL financial report.	'
Current Fiscal Year End Date	'--11-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Public Float	'	$2,776,858
Entity Common Stock, Shares Outstanding	'	185,123,890
Document Fiscal Period Focus	'FY	'
Document Fiscal Year Focus	'2013	'

Balance_Sheets

Balance Sheets (USD $)	Nov. 30, 2013	Nov. 30, 2012
CURRENT ASSETS	'	'
Cash	$114	$7
Prepaid Expenses	0	95,581
Notes Receivable	122,200	0
Short Term Investments	197,448	198,160
Total Current Assets	319,762	293,748
Property & Equipment (Net)	'	86,430
Intangible Assets	700,000	'
TOTAL ASSETS	1,019,762	380,178
CURRENT LIABILITIES	'	'
Bank Overdraft	'	'
Accounts Payable	974,854	972,551
Notes Payable - (Related Party)	45,244	46,352
Notes Payable	1,286,231	1,248,156
Total Current Liabilities	2,306,329	2,267,059
STOCKHOLDERS EQUITY	'	'
Preferred Stock $0.0001 par value, Authorized 80,000,000 shares, 0 shares issued and outstanding as of November 30, 2013 and November 30, 2012	'	'
Common Stock $0.0001 par value, 260,000,000 shares authorized: 164,473,890 shares issued and outstanding as of November 30, 2013 and 82,073,890 as of November 30, 2012	16,447	8,207
Paid-in capital	2,795,550	1,667,790
Deficit accumulated during the development stage	-4,098,564	-3,562,878
Total Stocksholders Equity	-1,286,567	-1,886,881
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$1,019,762	$380,178

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Statement of Financial Position [Abstract]	'	'
Preferred stock authorized shares	80,000,000	80,000,000
Preferred stock par value shares	$0.00	$0.00
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common stock authorized shares	260,000,000	260,000,000
Common stock par value shares	$0.00	$0.00
Common stock shares issued	164,473,890	82,073,890
Common stock shares outstanding	164,473,890	82,073,890

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		181 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Income Statement [Abstract]	'	'	'
REVENUES	$312,200	'	$1,257,011
Cost of revenues	'	'	'
GROSS PROFIT	312,200	'	653,948
OPERATING COSTS	'	'	'
Bad debt expense	'	'	120,844
Licensing rights	'	'	700,000
Depreciation expense	'	'	73,274
Marketing expense	'	'	236,266
Professional fees	15,000	11,000	240,295
Selling, general and administrative expense	671,388	215,875	2,403,119
Total operating costs	686,388	226,875	3,773,795
OPERATING (LOSS)	-374,188	-226,875	-3,119,850
OTHER INCOME & (EXPENSES)	'	'	'
Fx	30,787	-20,304	-18,419
Interest income	9,608	9,148	146,797
Other income (net)	'	'	85,005
Interest expense	-69,755	-68,505	-578,493
Write-down of leasehold improvements	'	'	-2,663
Write-up of notes receivable, related parties	'	'	11,435
Impairment Loss	-132,138	-86,428	-981,969
Gain on sale of investment	'	'	359,583
Total Other Income & (Expenses)	-161,498	-166,089	-978,714
NET INCOME (LOSS)	($535,686)	($392,964)	($4,098,564)
BASIC EARNINGS (LOSS) PER SHARE	$0	$0	'
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	99,842,657	82,073,890	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		181 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
NET INCOME (LOSS)	($535,686)	($392,964)	($4,098,564)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation expense	'	'	73,274
Common stock issued for services	436,000	'	872,143
Gain on sale of Investment	'	'	-359,583
Impairment Loss	132,138	86,428	981,969
Write-down of leasehold improvements	'	'	-2,663
Write-down of notes receivable	'	'	11,435
Accrued interest expense - note payable	69,755	68,505	469,005
Accrued interest income - notes receivable	-9,608	-9,148	-141,271
Changes in operating assets and liabilities:	'	'	'
(Increase) decrease in accounts receivable & prepaids	49,873	49,868	-45,708
(Increase) decrease in notes receivable	-111,880	-6,009	-578,068
Increase (decrease) in accounts payable	2,303	179,650	974,854
Net Cash Provided by (Used in) Operating Activities	32,895	-23,670	-1,860,721
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Net sale (purchase) of fixed assets	'	'	-60,937
Purchase of short term investments	'	'	-168,560
Proceeds from sale of investment shares	'	'	489,061
Net Cash Provided by (Used in) Investing Activities	'	'	259,564
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Issuance of common stock	'	'	156,262
Payment of common stock subscription receivable	'	'	206,239
Proceeds from-(payment) notes payable	-32,788	23,668	1,238,770
Net Cash Provided by (Used in) Financing Activities	-32,788	-2	1,601,271
Net Increase (Decrease) in Cash	107	9	114
Cash at Beginning of Year	7	'	'
Cash at End of Year	114	7	114
Supplemental Cash Flow Disclosures:	'	'	'
Cash paid during period for interest	'	'	'
Cash paid during period for taxes	'	'	'
Non-Cash flows activities	'	'	'
Shares issued for Intangible Assets	700,000	'	700,000
Shares issued for Property & Equipment	'	'	600,000
Shares issued for Goodwill	'	'	115,000
Note receivable -related party offset with Note payable	'	'	181,878
Note receivable exchanged for Goodwill	'	'	$216,261

Shareholders_Equity

Shareholders Equity (USD $)	Common Stock	Additional Paid-In Capital	Stock Subscription Receivable	(Deficit) Accumulated During the Development Stage	Total
Beginning Balance, Value at Nov. 30, 1998	'	'	'	'	'
Beginning Balance, Shares at Nov. 30, 1998	0	'	'	'	'
Rounding	'	'	'	'	'
Stock issued for cash, Shares	10,400,000	'	'	'	'
Stock issued for cash, Value	1,040	258,961	-103,739	'	156,262
Stock issued for equipment purchase, Shares	600,000	'	'	'	'
Stock issued for equipment purchase, Value	60	14,940	'	'	15,000
Stock issued in exchange for shares of Millenia Hope, Inc., Shares	35,700,000	'	'	'	'
Stock issued in exchange for shares of Millenia Hope, Inc., Value	3,570	125,908	'	'	129,478
Stock issued in exchange for notes payable, Shares	'	'	'	'	'
Collection on subscription	'	'	103,739	'	103,739
NET INCOME (LOSS)	'	'	'	-69,231	-69,231
Ending Balance, Value at Nov. 30, 2000	4,670	399,809	'	-69,231	335,248
Ending Balance, Shares at Nov. 30, 2000	46,700,000	'	'	'	'
Rounding	'	'	'	'	'
Stock issued for cash, Shares	410,000	'	'	'	'
Stock issued for cash, Value	41	309,959	-310,000	'	'
Stock issued in exchange for notes payable, Shares	'	'	'	'	'
NET INCOME (LOSS)	'	'	'	-1,679	-1,679
Ending Balance, Value at Nov. 30, 2001	4,711	709,768	-310,000	-70,910	333,569
Ending Balance, Shares at Nov. 30, 2001	47,110,000	'	'	'	'
Rounding	'	'	'	'	'
Stock issued for payment of consulting fees, Shares	92,500	'	'	'	'
Stock issued for payment of consulting fees, Value	9	18,491	'	'	18,500
Stock issued in exchange for professional fees, Shares	205,200	'	'	'	'
Stock issued in exchange for professional fees, Value	21	51,354	'	'	51,375
Stock issued in exchange for notes payable, Shares	'	'	'	'	'
Collection on subscription	'	-207,500	207,500	'	'
NET INCOME (LOSS)	'	'	'	-141,693	-141,693
Ending Balance, Value at Nov. 30, 2002	4,741	572,113	-102,500	-212,603	261,751
Ending Balance, Shares at Nov. 30, 2002	47,407,700	'	'	'	'
Rounding	300	'	'	'	'
Stock issued in exchange for marketing expense, Shares	600,000	'	'	'	'
Stock issued in exchange for marketing expense, Value	60	42,440	'	'	42,500
Stock issued in exchange for notes payable, Shares	257,500	'	'	'	'
Stock issued in exchange for notes payable, Value	26	12,849	'	'	12,875
Collection on subscription	'	'	102,500	'	102,500
NET INCOME (LOSS)	'	'	'	-715,903	-715,903
Ending Balance, Value at Nov. 30, 2003	4,827	627,402	'	-928,506	-296,277
Ending Balance, Shares at Nov. 30, 2003	48,265,500	'	'	'	'
NET INCOME (LOSS)	'	'	'	-12,936	-12,936
Ending Balance, Value at Nov. 30, 2004	4,827	627,402	'	-941,469	-309,240
Ending Balance, Shares at Nov. 30, 2004	48,265,500	'	'	'	'
Stock issued in exchange for professional fees, Value	'	'	'	'	'
NET INCOME (LOSS)	'	'	'	142,417	142,417
Ending Balance, Value at Nov. 30, 2005	4,827	627,402	'	-799,052	-166,823
Beginning Balance, Shares at Nov. 30, 2005	48,265,500	'	'	'	'
Stock issued in exchange for professional fees, Shares	1,000,000	'	'	'	'
Stock issued in exchange for professional fees, Value	100	900	'	'	1,000
NET INCOME (LOSS)	'	'	'	-47,203	-47,203
Ending Balance, Value at Nov. 30, 2006	4,927	628,302	'	-846,255	-213,026
Ending Balance, Shares at Nov. 30, 2006	49,265,500	'	'	'	'
Stock issued for equipment purchase, Shares	18,000,000	'	'	'	'
Stock issued for equipment purchase, Value	1,800	718,200	'	'	720,000
NET INCOME (LOSS)	'	'	'	-376,336	-376,336
Ending Balance, Value at Nov. 30, 2007	6,727	1,346,502	'	-1,222,591	130,638
Ending Balance, Shares at Nov. 30, 2007	67,265,500	'	'	'	'
NET INCOME (LOSS)	'	'	'	-63,371	-63,371
Ending Balance, Value at Nov. 30, 2008	6,727	1,346,502	'	-1,285,962	67,267
Ending Balance, Shares at Nov. 30, 2008	67,265,500	'	'	'	'
NET INCOME (LOSS)	'	'	'	-210,712	-210,712
Ending Balance, Value at Nov. 30, 2009	6,727	1,346,502	'	-1,496,674	-143,445
Beginning Balance, Shares at Nov. 30, 2009	67,265,500	'	'	'	'
Stock issued in exchange for professional fees, Shares	396,490	'	'	'	'
Stock issued in exchange for professional fees, Value	39	101,610	'	'	101,649
NET INCOME (LOSS)	'	'	'	-575,562	-575,562
Ending Balance, Value at Nov. 30, 2010	6,766	1,448,112	'	-2,072,236	-617,358
Ending Balance, Shares at Nov. 30, 2010	67,661,990	'	'	'	'
Stock issued in exchange for professional fees, Shares	14,411,900	'	'	'	'
Stock issued in exchange for professional fees, Value	1,441	219,678	'	'	221,119
NET INCOME (LOSS)	'	'	'	-1,097,678	-1,097,678
Ending Balance, Value at Nov. 30, 2011	8,207	1,667,790	'	-3,169,914	-1,493,917
Ending Balance, Shares at Nov. 30, 2011	82,073,890	'	'	'	'
Stock issued in exchange for professional fees, Value	'	'	'	'	'
Collection on subscription	'	'	'	'	'
NET INCOME (LOSS)	'	'	'	-392,964	-392,964
Ending Balance, Value at Nov. 30, 2012	8,207	1,667,790	'	-3,562,878	-1,886,881
Beginning Balance, Shares at Nov. 30, 2012	82,073,890	'	'	'	'
Stock issued for equipment purchase, Shares	70,000,000	'	'	'	'
Stock issued for equipment purchase, Value	7,000	693,000	'	'	700,000
Stock issued in exchange for professional fees, Shares	12,400,000	'	'	'	'
Stock issued in exchange for professional fees, Value	1,240	434,760	'	'	436,000
NET INCOME (LOSS)	'	'	'	-535,686	-535,686
Ending Balance, Value at Nov. 30, 2013	$16,447	$2,795,550	'	($4,098,564)	($1,286,567)
Ending Balance, Shares at Nov. 30, 2013	164,473,890	'	'	'	'

NOTE_1_ORGANIZATION_AND_DESCRI

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
1. ORGANIZATION AND DESCRIPTION OF BUSINESS	'
	NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS
	PURTHANOL RESOURCES LIMITED (formerly GLOBAL BIOTECH CORP.) (the ``Company``) was incorporated in the State of Delaware on November 2, 1998 to be an Application Service provider in the E-Health sector. On March 5, 2003 this business was sold, market, unsuccessfully. On February 25, 2005 it discontinued its vehicle tracking business. On August 15, 2007 the Company entered the oxygenated beverage market. Global’s current mission is to use the Purthonal process methodology, acquired in October 2013, to produce an ethanol fuel alternative. The Company changed name form Global Biotech Corp. to Purthanol Resources Limited on September 30, 2013

NOTE_2_SUMMARY_OF_SIGNIFICANT_

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	a. Accounting Method
	The Company's policy is to use the accrual method of accounting to prepare and present financial statements, which conforms to US generally accepted accounting principles ("GAAP'). The company has elected a November 30 year- end.
	b. Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less and bank indebtedness to be cash and cash equivalents. Highly liquid investments are valued at quoted market prices.
	c. Estimates and Adjustments
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from those estimates.
	Significant estimates made by management are, among others, realizability of long-lived assets, and deferred taxes. Management reviews its estimates on a quarterly basis and, where necessary, makes adjustments prospectively.
	d. Basis of Presentation and Considerations Related to Continued Existence (going concern)
	The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
	The Company's management intends to raise additional operating funds through operations, and debt or equity offerings. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings.
	e. Fair Value of Financial Instruments
	ASC 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
	Fair Value Hierarchy
	ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
	Level 1 applies to assets and liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.
	Level 2 applies to assets and liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance:
	• Determining which instruments are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced; and
	• Determining whether a market is considered active requires management judgment.
	Level 3 applies to assets and liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of
	The Company believes the fair value of its financial instruments consisting of cash, short term investment, and accounts payable approximate their carrying values due to the relatively short maturity of these instruments.
	f. Property & Equipment
	Property is stated at cost. Additions, renovations, and improvements are capitalized. Maintenance and repairs, which do not extend asset lives, are expensed as incurred.
	g. Depreciation
	Depreciation is provided on a straight-line basis over the estimated useful lives, 5 years for tenant improvements, and 5 - 7 years for equipment.
	h. Impairment of Long-Lived Assets
	Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the estimated undiscounted cash flows, expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of such assets.
	i. Revenue Recognition and Deferred Revenue
	The Company's revenues recognized from inception to November 30, 2013 were software consultation. Revenue, in respect of all services described, is recognized on completion of services, when collectability is reasonably assured.
	j. Foreign Currency Exchange
	We record our transactions in US dollars.
	Foreign currency accounts have been translated as follows:
	•	Monetary items - at exchange rates in effect at the balance sheet date
	•	Non-monetary item - at exchange rates in effect of the dates of transactions
	•	Revenue and expenses - at average exchange rate prevailing during the year.
	Gains and losses arising from foreign currency translation are included in income.
	k. Earning (Loss) Per Share
	The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC 260 effective November 2, 1998 (inception).
	Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.
	l. Stock-Based Compensation
	The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Based Compensation, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.
	m. Convertible Debt
	In accordance with Codifications topic 470 ”Debt with conversion and Other Options” the Company evaluates debt securities (“Debt”) for beneficial conversion features. A beneficial conversion feature is present when the conversion price per share is less than the market value of the common stock at the commitment date. The intrinsic value of the feature is then measured as the difference between the conversion price and the market value (the “Spread”) multiplied by the number of shares into which the Debt is convertible and is recorded as debt discount with an offsetting amount increasing additional paid-in-capital. The debt discount is accreted to interest expense over the term of the Debt with any unamortized discount recognized as interest expense upon conversion of the Debt. If a debt security contains terms that change upon the occurrence of a future event the incremental intrinsic value is measured as the additional number of issuable shares multiplied by the commitment date market value and is recognized as additional debt discount with an offsetting amount increasing additional paid-in-capital upon the future event occurrence. The total intrinsic value of the feature is limited to the proceeds allocated to the Debt instrument.
	n. Recent Accounting Pronouncements
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE_3_GOING_CONCERN

NOTE 3. GOING CONCERN	12 Months Ended
	Nov. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
3. GOING CONCERN	'
	NOTE 3. GOING CONCERN
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company generated net losses of $535,686 for the year ended November 30, 2013 and a net loss of $4,098,564 during the period from November 2, 1998 (inception) through November 30, 2013. At November 30, 2013 the Company had negative working capital of $1,986,567 and stockholders’ deficit of $1,286,567. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	The officers and directors are committed to help in raising funds to fill any operating cash flow shortages during the next fiscal year until the organization can generate sufficient funds from operations to meet current operating expenses and overhead, although there are no guarantees that this commitment will be met.

NOTE_4_SHORT_TERM_INVESTMENTS

NOTE 4. SHORT TERM INVESTMENTS	12 Months Ended
	Nov. 30, 2013
Summary of Investments, Other than Investments in Related Parties [Abstract]	'
4. SHORT TERM INVESTMENTS	'
	NOTE 4. SHORT TERM INVESTMENTS
	On November 6, 2010, the Company purchased a term deposit in the amount of $163,400 USD, ($172,000CDN) bearing interest rate of 5%. On November 6, 2013 they extended the maturity date to November 6, 2014. As of November 30, 2013 the Company accrued $34,048 USD of interest income. No withdrawals allowed for first 90 days and 90 days early withdrawal notice needed. Early withdrawal interest rate - 1 ½%.

NOTE_5_PROPERTY_EQUIPMENT

NOTE 5. PROPERTY & EQUIPMENT	12 Months Ended
	Nov. 30, 2013
Property, Plant and Equipment [Abstract]	'
5. PROPERTY & EQUIPMENT	'
	NOTE 5. PROPERTY & EQUIPMENT
	On August 15, 2007 the Company acquired Oxygenation Equipment with a cost of $605,000 in exchange for common shares.
		30-Nov-13		30-Nov-12
	Oxygenation Equipment	$	605,000	$	605,000
	Less: Impairment Loss		605,000		518,570
	Net Property and Equipment	$	0	$	86,430
	Company recognized impairment losses of $86,430 and $86,428 for the years ended November 30, 2013 and 2012, respectively.

NOTE_6_INTANGIBLE_ASSETS

NOTE 6. INTANGIBLE ASSETS	12 Months Ended
	Nov. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
6. INTANGIBLE ASSETS	'
	NOTE 6. INTANGIBLE ASSETS
	On September 10, 2013 the Company acquired all the intellectual property, process know-how and methodology, etc. for the production of Athanol (the name used by Purthanol International for its green- technology ethanol fuel alternative), or any other ethanol fuel alternative produced via the Purthanol Process.
	The cost of the above transaction, $700,000, was paid by Purthanol issuing from its treasury seventy million (70 million) common shares.

NOTE_7_BASIC_DILUTED_INCOME_LO

NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE	12 Months Ended
	Nov. 30, 2013
Earnings Per Share [Abstract]	'
7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE	'
	NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE
	Basic gain (loss) per common share has been calculated based on the weighted average number of shares of common stock outstanding during the period. Diluted gain (loss) per common share has been calculated based on the weighted average number of shares of common and preferred stock outstanding during the period.
			30-Nov-13			30-Nov-12
	Net income (Loss) from operations	$	(535,686	)	$	(392,964	)
	Basic income / (loss) per share	$	(0.00	)	$	(0.00	)
	Weighted average number of shares outstanding		99,842,657			82,073,890

NOTE_8_NOTES_PAYABLE

NOTE 8. NOTES PAYABLE	12 Months Ended
	Nov. 30, 2013
Debt Disclosure [Abstract]	'
8. NOTES PAYABLE	'
	NOTE 8. NOTES PAYABLE
	Note payable as of November 30, 2013 and 2012 consist of the following:
			2013		2012
	Note payable to: Millenia Hope Inc. unsecured, with annual interest rate 7%.	$	652,110	$	608,392
	Third parties, unsecured with annual interest of 4%, commencing July 1, 2009		105,063		107,063
	Convertible note payable to third parties with annual interest of 2%, commencing March 1, 2011 Loan is convertible to common shares of Global Biotech at par to the lowest daily trading price of the shares on the conversion request date		205,319		213,612
	Convertible note payble to third parties with annual interest of 8%, commencing April 30, 2009 Loan is convertible to common shares of Global Biotech at the lesser of $1.00 per share or the average closing price of the shares for the 5 business days prior to conversion		323,739		319,089
		$	1,286,231	$	1,248,156
	Included in the Notes payable is Millenia Hope due $652,110, who had a common officer with the company, Leonard Stella.
	There are no beneficial conversion features because the Company has conversion right.

NOTE_9_LICENSING_RIGHTS

NOTE 9. LICENSING RIGHTS	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
9. LICENSING RIGHTS	'
	NOTE 9. LICENSING RIGHTS
	On October 11, 2013, Purthanol Quebec, an arm’s length corporation, acquired from the Company the rights to use the Purthanol Process to extract ethanol, in the Province of Quebec, Canada for $312,200. All sales of said extracted ethanol are to be done through Purthanol Resources and the gross profit on these sales, less standard distribution and delivery costs, will be split on a 50-50 basis between the 2 companies. The Company recognized $312,200 as revenue.

NOTE_10_INCOME_TAXES

NOTE 10. INCOME TAXES	12 Months Ended
	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'
10. INCOME TAXES	'
	NOTE 10. INCOME TAXES
	Income taxes are provided in accordance with ASC 740, Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carry-forwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.
	The net operating loss expires twenty years from the date the loss was incurred. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	No portion of the valuation allowance will be allocated to reduce goodwill or other non-current intangible asset of an acquired entity. There are no temporary differences or carry-forward tax effects that would significantly effect the Companies deferred tax asset.
	Utilization of the net operating losses and credit carry-forwards may be subject to a substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986. The annual limitation may result in the expiration of net operating losses and credits before utilization. At November 30, 2013 the Company had net operating losses carry-forward of $4,098,564. The tax benefits resulting for these losses have been estimated as follows:
			30-Nov-13
	Gross income tax benefit	$	1,434,000
	Valuation Allowance		1,434,000
	Net Income Tax Benefit	$	0
	Deficit - December 1, 2012	$	(3,562,878	)
	Net Loss for Year ended November 30, 2013		(535,686	)
	Deficit - November 30, 2013	$	(4,098,564	)

NOTE_11_STOCK_TRANSACTIONS

NOTE 11. STOCK TRANSACTIONS	12 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
11. STOCK TRANSACTIONS	'
	NOTE 11. STOCK TRANSACTIONS
	On September 10, 2013 the Company issued 70,000,000 common shares in settlement of property and equipment of $700,000.
	On September 23, 2013 the Company issued 2,400,000 common shares in settlement of consulting fees of $36,000
	On October 4, 2013 the Company issued 10,000,000 common shares in settlement of consulting fees of $400,000
	As of November 30, 2013 the Company had 164,473,890 shares of common stock issued and outstanding

NOTE_12_STOCKHOLDERS_EQUITY

NOTE 12. STOCKHOLDERS EQUITY	12 Months Ended
	Nov. 30, 2013
Equity [Abstract]	'
12. STOCKHOLDERS EQUITY	'
	NOTE 12. STOCKHOLDERS' EQUITY
	The stockholders' equity section of the Company contains the following classes of capital stock as of November 30, 2013 and 2012:
	Common stock, $ 0.0001 par value; 260,000,000 shares and 260,000,000 shares authorized November 30, 2012 and 2013: 82,073,890 shares issued and outstanding as of November 30, 2012 and 164,473,890 as of November 30, 2013.
	Preferred Stock, $0.0001 par value; 80,000,000 shares authorized as November 30, 2012 and November 30, 2013. Zero (0) shares issued and outstanding, as of November 30, 2012 and 2013.

NOTE_13_RELATED_PARTY_TRANSACT

NOTE 13. RELATED PARTY TRANSACTIONS	12 Months Ended
	Nov. 30, 2013
Related Party Transactions [Abstract]	'
13. RELATED PARTY TRANSACTIONS	'
	NOTE 13. RELATED PARTY TRANSACTIONS
	As of November 30, 2013 the Company owed two of its officers, Leonard Stella, CEO, and Yehuda Kops, CFO, $846,362 of administrative fees. This amount is included in the Accounts payable.
	The Notes payable related is due to its former President, Louis Greco.

NOTE_14_SUBSEQUENT_EVENTS

NOTE 14. SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2013
Subsequent Events [Abstract]	'
14. SUBSEQUENT EVENTS	'
	NOTE 14. SUBSEQUENT EVENTS
	In accordance with ASC 855, Subsequent Events, the Company has evaluated subsequent events through the date of issuance of the audited financial statements. During this period, the Company had the following subsequent event.
	On December 16, 2013, Global acquired 100% of all outstanding shares of Biocardel Quebec, a privately held company, for $5 million, payable $100,000 at signing of the agreement, $2,400,000 in 9 months, as a balance of sale and $2,500,000 in preferred convertible shares, at a 25% discount to the 90 trading -day average sales price of the common shares, whenever Global chooses to exercise the conversion rights. Biocardel owns a production facility in Richmond, Quebec, that turns biologic oil waste products and byproducts into biodiesel fuel, a commodity in demand in both North America and Europe.
	On February 25, 2014 the Company issued 650,000 common shares in settlement of consulting fees of $9,750.

NOTE_2_SUMMARY_OF_SIGNIFICANT_1

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
a. Accounting Method	'
	a. Accounting Method
	The Company's policy is to use the accrual method of accounting to prepare and present financial statements, which conforms to US generally accepted accounting principles ("GAAP'). The company has elected a November 30 year- end.
b. Cash and Cash Equivalents	'
	b. Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less and bank indebtedness to be cash and cash equivalents. Highly liquid investments are valued at quoted market prices.
c. Estimates and Adjustments	'
	c. Estimates and Adjustments
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from those estimates.
	Significant estimates made by management are, among others, realizability of long-lived assets, and deferred taxes. Management reviews its estimates on a quarterly basis and, where necessary, makes adjustments prospectively.
d. Basis of Presentation and Considerations Related to Continued Existence (going concern)	'
	d. Basis of Presentation and Considerations Related to Continued Existence (going concern)
	The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
	The Company's management intends to raise additional operating funds through operations, and debt or equity offerings. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings.
e. Fair Value of Financial Instruments	'
	e. Fair Value of Financial Instruments
	ASC 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
	Fair Value Hierarchy
	ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
	Level 1 applies to assets and liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.
	Level 2 applies to assets and liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance:
	• Determining which instruments are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced; and
	• Determining whether a market is considered active requires management judgment.
	Level 3 applies to assets and liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of
	The Company believes the fair value of its financial instruments consisting of cash, short term investment, and accounts payable approximate their carrying values due to the relatively short maturity of these instruments.
f. Property & Equipment	'
	f. Property & Equipment
	Property is stated at cost. Additions, renovations, and improvements are capitalized. Maintenance and repairs, which do not extend asset lives, are expensed as incurred.
g. Depreciation	'
	g. Depreciation
	Depreciation is provided on a straight-line basis over the estimated useful lives, 5 years for tenant improvements, and 5 - 7 years for equipment.
h. Impairment of Long-Lived Assets	'
	h. Impairment of Long-Lived Assets
	Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the estimated undiscounted cash flows, expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of such assets.
i. Revenue Recognition and Deferred Revenue	'
	i. Revenue Recognition and Deferred Revenue
	The Company's revenues recognized from inception to November 30, 2013 were software consultation. Revenue, in respect of all services described, is recognized on completion of services, when collectability is reasonably assured.
j. Foreign Currency Exchange	'
	j. Foreign Currency Exchange
	We record our transactions in US dollars.
	Foreign currency accounts have been translated as follows:
	•	Monetary items - at exchange rates in effect at the balance sheet date
	•	Non-monetary item - at exchange rates in effect of the dates of transactions
	•	Revenue and expenses - at average exchange rate prevailing during the year.
	Gains and losses arising from foreign currency translation are included in income.
k. Earning (Loss) Per Share	'
	k. Earning (Loss) Per Share
	The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC 260 effective November 2, 1998 (inception).
	Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.
l. Stock-Based Compensation	'
	l. Stock-Based Compensation
	The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Based Compensation, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.
m. Convertible Debt	'
	m. Convertible Debt
	In accordance with Codifications topic 470 ”Debt with conversion and Other Options” the Company evaluates debt securities (“Debt”) for beneficial conversion features. A beneficial conversion feature is present when the conversion price per share is less than the market value of the common stock at the commitment date. The intrinsic value of the feature is then measured as the difference between the conversion price and the market value (the “Spread”) multiplied by the number of shares into which the Debt is convertible and is recorded as debt discount with an offsetting amount increasing additional paid-in-capital. The debt discount is accreted to interest expense over the term of the Debt with any unamortized discount recognized as interest expense upon conversion of the Debt. If a debt security contains terms that change upon the occurrence of a future event the incremental intrinsic value is measured as the additional number of issuable shares multiplied by the commitment date market value and is recognized as additional debt discount with an offsetting amount increasing additional paid-in-capital upon the future event occurrence. The total intrinsic value of the feature is limited to the proceeds allocated to the Debt instrument.
n. Recent Accounting Pronouncements	'
	n. Recent Accounting Pronouncements
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE_5_PROPERTY_EQUIPMENT_Tabl

NOTE 5. PROPERTY & EQUIPMENT (Tables)	12 Months Ended
	Nov. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
		30-Nov-13		30-Nov-12
	Oxygenation Equipment	$	605,000	$	605,000
	Less: Impairment Loss		605,000		518,570
	Net Property and Equipment	$	0	$	86,430

NOTE_7_BASIC_DILUTED_INCOME_LO1

NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE (Tables)	12 Months Ended
	Nov. 30, 2013
Earnings Per Share [Abstract]	'
Basic and Diluted Income / (Loss) Per Common Share	'
			30-Nov-13			30-Nov-12
	Net income (Loss) from operations	$	(535,686	)	$	(392,964	)
	Basic income / (loss) per share	$	(0.00	)	$	(0.00	)
	Weighted average number of shares outstanding		99,842,657			82,073,890

NOTE_8_NOTES_PAYABLE_Tables

NOTE 8. NOTES PAYABLE (Tables)	12 Months Ended
	Nov. 30, 2013
Debt Disclosure [Abstract]	'
Notes Payable	'
			2013		2012
	Note payable to: Millenia Hope Inc. unsecured, with annual interest rate 7%.	$	652,110	$	608,392
	Third parties, unsecured with annual interest of 4%, commencing July 1, 2009		105,063		107,063
	Convertible note payable to third parties with annual interest of 2%, commencing March 1, 2011 Loan is convertible to common shares of Global Biotech at par to the lowest daily trading price of the shares on the conversion request date		205,319		213,612
	Convertible note payble to third parties with annual interest of 8%, commencing April 30, 2009 Loan is convertible to common shares of Global Biotech at the lesser of $1.00 per share or the average closing price of the shares for the 5 business days prior to conversion		323,739		319,089
		$	1,286,231	$	1,248,156

NOTE_10_INCOME_TAXES_Tables

NOTE 10. INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Benefits	'
			30-Nov-13
	Gross income tax benefit	$	1,434,000
	Valuation Allowance		1,434,000
	Net Income Tax Benefit	$	0
	Deficit - December 1, 2012	$	(3,562,878	)
	Net Loss for Year ended November 30, 2013		(535,686	)
	Deficit - November 30, 2013	$	(4,098,564	)

NOTE_3_GOING_CONCERN_Details_N

NOTE 3. GOING CONCERN (Details Narrative) (USD $)

12 Months Ended

24 Months Ended

181 Months Ended

Nov. 30, 2013

Nov. 30, 2012

Nov. 30, 2011

Nov. 30, 2010

Nov. 30, 2009

Nov. 30, 2008

Nov. 30, 2007

Nov. 30, 2006

Nov. 30, 2005

Nov. 30, 2004

Nov. 30, 2003

Nov. 30, 2002

Nov. 30, 2001

Nov. 30, 2000

Nov. 30, 2013

Nov. 30, 1998

Organization, Consolidation and Presentation of Financial Statements [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

NET INCOME (LOSS)

($535,686)

($392,964)

($1,097,678)

($575,562)

($210,712)

($63,371)

($376,336)

($47,203)

$142,417

($12,936)

($715,903)

($141,693)

($1,679)

($69,231)

($4,098,564)

'

Working Capital

-1,986,567

'

'

'

'

'

'

'

'

'

'

'

'

'

-1,986,567

'

Stockholders Equity

($1,286,567)

($1,886,881)

($1,493,917)

($617,358)

($143,445)

$67,267

$130,638

($213,026)

($166,823)

($309,240)

($296,277)

$261,751

$333,569

$335,248

($1,286,567)

'

NOTE_4_SHORT_TERM_INVESTMENTS_

NOTE 4. SHORT TERM INVESTMENTS (Details Narrative) (USD $)	Nov. 30, 2013	Nov. 06, 2010
Term Deposit	'	$163,400
Term Deposit, Interest Rate	'	500.00%
Term Deposit, Accrued Interest Income	34,048	'
Term Deposit, Early Withdrawal Interest Rate	'	1.50%
Canada, Dollars	'	'
Term Deposit	'	($172,000)

NOTE_5_PROPERTY_EQUIPMENT_Prop

NOTE 5. PROPERTY & EQUIPMENT - Property and Equipment (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Property, Plant and Equipment [Abstract]	'	'
Oxygenation equipment	$605,000	$605,000
Less: Impairment Loss	605,000	518,570
Net Property and Equipment	'	$86,430

NOTE_5_PROPERTY_EQUIPMENT_Deta

NOTE 5. PROPERTY & EQUIPMENT (Details Narrative) (USD $)	12 Months Ended			181 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2007	Nov. 30, 2013
Property, Plant and Equipment [Abstract]	'	'	'	'
Property and Equipment, Cost of Acquisition	'	'	$605,000	'
Impairment Losses	$132,138	$86,428	'	$981,969

NOTE_6_INTANGIBLE_ASSETS_Detai

NOTE 6. INTANGIBLE ASSETS (Details Narrative) (USD $)	12 Months Ended	181 Months Ended
	Nov. 30, 2013	Nov. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
Cost to Acquire Intangible Assets, Value	$700,000	$700,000
Cost to Acquire Intangible Assets, Shares	70,000,000	'

NOTE_7_BASIC_DILUTED_INCOME_LO2

NOTE 7. BASIC & DILUTED INCOME / (LOSS) PER COMMON SHARE - Basic and Diluted Income / (Loss) Per Common Share (Details) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Earnings Per Share [Abstract]	'	'
Net income (loss) from operations	($535,686)	($392,964)
Basic income / (loss) per share	$0	$0
Weighed average number of shares outstanding	99,842,657	82,073,890

NOTE_8_NOTES_PAYABLE_Notes_Pay

NOTE 8. NOTES PAYABLE - Notes Payable (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Notes Payable	$1,286,231	$1,248,156
Millenia Hope [Member]	'	'
Notes Payable	652,110	608,392
Third Parties, Unsecured	'	'
Notes Payable	105,063	107,063
Convertible Note, Third Parties 1	'	'
Notes Payable	205,319	213,612
Convertible Note, Third Parties 2	'	'
Notes Payable	$323,739	$319,089

NOTE_8_NOTES_PAYABLE_Details_N

NOTE 8. NOTES PAYABLE (Details Narrative) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Note Payable - Related Party	$45,244	$46,352
Millenia Hope [Member]	'	'
Note Payable - Related Party	$652,110	'

NOTE_9_LICENSING_RIGHTS_Detail

NOTE 9. LICENSING RIGHTS (Details Narrative) (USD $)	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
Revenue from Sale of Rights	$312,200

NOTE_10_INCOME_TAXES_Income_Ta

NOTE 10. INCOME TAXES - Income Tax Benefits (Details) (USD $)

12 Months Ended

24 Months Ended

181 Months Ended

Nov. 30, 2013

Nov. 30, 2012

Nov. 30, 2011

Nov. 30, 2010

Nov. 30, 2009

Nov. 30, 2008

Nov. 30, 2007

Nov. 30, 2006

Nov. 30, 2005

Nov. 30, 2004

Nov. 30, 2003

Nov. 30, 2002

Nov. 30, 2001

Nov. 30, 2000

Nov. 30, 2013

Income Tax Disclosure [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross income tax benefit

$1,434,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Valuation Allowance

1,434,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net Income Tax Benefit

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deficit - December 1, 2012

-3,562,878

'

'

'

'

'

'

'

'

'

'

'

'

'

'

NET INCOME (LOSS)

-535,686

-392,964

-1,097,678

-575,562

-210,712

-63,371

-376,336

-47,203

142,417

-12,936

-715,903

-141,693

-1,679

-69,231

-4,098,564

Deficit - November 30, 2013

($4,098,564)

($3,562,878)

'

'

'

'

'

'

'

'

'

'

'

'

($4,098,564)

NOTE_10_INCOME_TAXES_Details_N

NOTE 10. INCOME TAXES (Details Narrative) (USD $)	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'
Net Operating Loss Carry-Forward	$4,098,564

NOTE_11_STOCK_TRANSACTIONS_Det

NOTE 11. STOCK TRANSACTIONS (Details Narrative) (USD $)	1 Months Ended		9 Months Ended	12 Months Ended			24 Months Ended
	Oct. 31, 2013	Sep. 30, 2013	Aug. 30, 2014	Nov. 30, 2013	Nov. 30, 2007	Nov. 30, 2002	Nov. 30, 2000	Nov. 30, 2012
Notes to Financial Statements	'	'	'	'	'	'	'	'
Stock Issued for Purchase of Property and Equipment, Shares	'	70,000,000	'	'	'	'	'	'
Stock Issued for Purchase of Property and Equipment, Value	'	$700,000	'	$700,000	$720,000	'	$15,000	'
Stock issued for payment of consulting fees, Shares	10,000,000	2,400,000	650,000	'	'	'	'	'
Stock issued for payment of consulting fees, Value	$400,000	$36,000	$9,750	'	'	$18,500	'	'
Common Stock, Shares Issued	'	'	'	164,473,890	'	'	'	82,073,890
Common Stock, Shares Outstanding	'	'	'	164,473,890	'	'	'	82,073,890

NOTE_12_STOCKHOLDERS_EQUITY_De

NOTE 12. STOCKHOLDERS EQUITY (Details Narrative) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Equity [Abstract]	'	'
Preferred stock authorized shares	80,000,000	80,000,000
Preferred stock par value shares	$0.00	$0.00
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common stock authorized shares	260,000,000	260,000,000
Common stock par value shares	$0.00	$0.00
Common stock shares issued	164,473,890	82,073,890
Common stock shares outstanding	164,473,890	82,073,890

NOTE_13_RELATED_PARTY_TRANSACT1

NOTE 13. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	12 Months Ended
	Nov. 30, 2013
Related Party Transactions [Abstract]	'
Administrative Fees	$846,362

NOTE_14_SUBSEQUENT_EVENTS_Deta

NOTE 14. SUBSEQUENT EVENTS (Details Narrative) (USD $)	1 Months Ended			9 Months Ended	12 Months Ended	24 Months Ended
	Dec. 31, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 30, 2014	Nov. 30, 2002	Nov. 30, 2000
Subsequent Events [Abstract]	'	'	'	'	'	'
Percentage of Ownership Acquired	100.00%	'	'	'	'	'
Acquisition Costs	$5	'	'	'	'	'
Acquisition Payments	100,000	'	'	2,400,000	'	'
Stock issued for payment of consulting fees, Shares	'	10,000,000	2,400,000	650,000	'	'
Stock issued for payment of consulting fees, Value	'	400,000	36,000	9,750	18,500	'
Stock issued for acquisition, Value	'	'	'	$2,500,000	'	$129,478